Skip to search.
 TSX Down 0.12% TSX Ventures Up 0.13%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
0.41 0.00(0.00%) Jan 13, 4:00PM EST
Prev Close:0.41
Open:0.44
Bid:0.40 x 10700
Ask:0.95 x 2000
1y Target Est:16.00
Beta:1.71038
Earnings Date:Mar 20 - Mar 24 (Est.)
Day's Range:0.40 - 0.45
52wk Range:0.39 - 8.16
Volume:1,301,172
Avg Vol (3m):476,490
Market Cap:889.96k
P/E (ttm):N/A
EPS (ttm):-10.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
DCTH 0.00%889.96k
ONXXF 0.00%N/A
LLYUp 0.32%81.20B
PFEDown 0.25%197.34B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.51
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.72
Quarterly EPS Est (Dec-16) :-3.24
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.01

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback